Finally, with data collected since 2005, we characterized the progression of IGF1 concentrations between weeks 3 and 5 of life in pre-term newborns with and without ROP in order to better understand the evolution and development of the disease. The gene discussed is IGF1; the disease is retinopathy of prematurity.